DSM-Firmenich AG

ENXTAM:DSM 주식 보고서

시가총액: €763.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DSM-Firmenich 과거 수익 실적

과거 기준 확인 1/6

DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 10.1% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.

주요 정보

-20.7%

수익 성장률

-20.2%

EPS 성장률

Chemicals 산업 성장1.6%
매출 성장률-0.8%
자기자본 수익률4.4%
순이익5.4%
다음 실적 업데이트02 Aug 2023

최근 과거 실적 업데이트

Recent updates

Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher

May 04
Analyst Forecasts For Koninklijke DSM N.V. (AMS:DSM) Are Surging Higher

Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return

Mar 27
Koninklijke DSM (AMS:DSM) Is Reinvesting At Lower Rates Of Return

Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Mar 09
Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching

Dec 06
Here's Why We Think Koninklijke DSM (AMS:DSM) Is Well Worth Watching

Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Nov 18
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)

Oct 31
Estimating The Fair Value Of Koninklijke DSM N.V. (AMS:DSM)

Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching

Sep 19
Why Koninklijke DSM N.V. (AMS:DSM) Could Be Worth Watching

Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?

Aug 23
Is Now The Time To Put Koninklijke DSM (AMS:DSM) On Your Watchlist?

Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Aug 08
Is Koninklijke DSM (AMS:DSM) Using Too Much Debt?

Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)

Jul 23
Calculating The Intrinsic Value Of Koninklijke DSM N.V. (AMS:DSM)

Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Apr 30
Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Apr 16
Koninklijke DSM (AMS:DSM) Is Increasing Its Dividend To €1.70

Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's

Apr 02
Koninklijke DSM's (AMS:DSM) Upcoming Dividend Will Be Larger Than Last Year's

Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70

Mar 19
Koninklijke DSM's (AMS:DSM) Dividend Will Be Increased To €1.70

Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly

Feb 19
Koninklijke DSM (AMS:DSM) Seems To Use Debt Rather Sparingly

Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?

Nov 23
Are Koninklijke DSM N.V. (AMS:DSM) Investors Paying Above The Intrinsic Value?

We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt

Oct 01
We Think Koninklijke DSM (AMS:DSM) Can Stay On Top Of Its Debt

Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?

Aug 24
Does This Valuation Of Koninklijke DSM N.V. (AMS:DSM) Imply Investors Are Overpaying?

Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet

Jun 29
Koninklijke DSM (AMS:DSM) Has A Pretty Healthy Balance Sheet

Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price

May 24
Koninklijke DSM N.V.'s (AMS:DSM) Intrinsic Value Is Potentially 17% Below Its Share Price

Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Mar 29
Is Koninklijke DSM (AMS:DSM) A Risky Investment?

Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?

Mar 15
Should Koninklijke DSM N.V. (AMS:DSM) Be Part Of Your Dividend Portfolio?

Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Mar 01
Are Koninklijke DSM N.V.'s (AMS:DSM) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment

Feb 16
Koninklijke DSM (AMS:DSM) Has Gifted Shareholders With A Fantastic 276% Total Return On Their Investment

Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

Feb 04
Need To Know: Koninklijke DSM N.V. (AMS:DSM) Insiders Have Been Selling Shares

수익 및 비용 분석

DSM-Firmenich 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

ENXTAM:DSM 수익, 비용 및 수입 (EUR Millions )
날짜수익수익G+A 비용R&D 비용
31 Dec 228,3904541,772295
30 Sep 229,582837895162
30 Jun 229,8021,0821,789323
31 Mar 229,5031,0811,789323
31 Dec 217,2698201,649274
30 Sep 217,9556602,517560
30 Jun 217,5584931,622398
31 Mar 217,5724231,622398
31 Dec 208,1064481,622398
30 Sep 207,9605101,639295
30 Jun 208,0345571,639295
31 Mar 209,0117221,795349
31 Dec 197,9986751,639295
30 Sep 198,2728201,839348
30 Jun 198,5027941,839348
31 Mar 199,1249341,839348
31 Dec 189,2671,0691,839348
30 Sep 189,2359841,753334
30 Jun 189,1062,0821,753334
31 Mar 188,9081,9421,753334
31 Dec 178,6321,7611,753334
30 Sep 178,4711,6761,694309
30 Jun 178,3337381,694309
31 Mar 178,1667111,694309
31 Dec 167,9206451,694309
30 Sep 167,8315881,605332
30 Jun 167,7782741,605332
31 Mar 167,7492141,605332
31 Dec 157,7221741,605332
30 Sep 157,607661,382304
30 Jun 157,4561141,382304
31 Mar 157,2451151,382304
31 Dec 147,0511231,382304
30 Sep 147,4151121,430340
30 Jun 147,8341381,430340
31 Mar 148,3621821,430340
31 Dec 138,8582521,430340
30 Sep 138,4093631,396372
30 Jun 138,5003351,396372
31 Mar 138,4862571,396372
31 Dec 128,5882801,396372
30 Sep 129,0894531,356378
30 Jun 129,1075431,356378

양질의 수익: DSM has high quality earnings.

이익 마진 증가: DSM's current net profit margins (5.4%) are lower than last year (11.3%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: DSM's earnings have declined by 20.7% per year over the past 5 years.

성장 가속화: DSM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: DSM had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-19.7%).


자기자본 수익률

높은 ROE: DSM's Return on Equity (4.4%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기